Growth and the pubertal growth spurt in South African adolescents living with perinatally-acquired HIV infection

Show simple item record

dc.contributor.author Mwambenu, Bilema
dc.contributor.author Ramoloko, Vundli
dc.contributor.author Laubscher, Ria
dc.contributor.author Feucht, Ute Dagmar
dc.date.accessioned 2022-11-07T09:26:06Z
dc.date.available 2022-11-07T09:26:06Z
dc.date.issued 2022-01-25
dc.description.abstract BACKGROUND : The majority children living with HIV infection now survive into adulthood because of effective antiretroviral therapy (ART), but few data exist on their growth during adolescent years. This study investigated growth patterns and evaluated factors associated with suboptimal growth in adolescents with perinatally-acquired HIV infection. METHODS : This retrospective cohort study included HIV-infected adolescents, aged 13 to 18 years, with at least 5 years of ART follow-up at a large HIV clinic in the Gauteng Province, South Africa. Weight-for-age Z-scores (WAZ), height-for-age Z-scores (HAZ) and body mass index (BMI)-for-age Z-scores were calculated using World Health Organization (WHO) growth standards. Growth velocity graphs were generated utilising the mean height change calculated at 6-monthly intervals, using all available data after ART initiation, to calculate the annual change. Other collected data included WHO HIV disease staging, CD4%, HIV viral loads (VLs), ART regimens and tuberculosis co-infection. RESULTS : Included were 288 children with a median age of 6.5 years (IQR 4.2;8.6 years) at ART initiation, and 51.7% were male. At baseline the majority of children had severe disease (92% WHO stages 3&4) and were started on non-nucleoside reverse transcriptase inhibitorbased regimens (79.2%). The median CD4% was 13.5% (IQR 7.9;18.9) and median HIV viral load log 5.0 (IQR 4.4;5.5). Baseline stunting (HAZ <-2) was prevalent (55.9%), with a median HAZ of -2.2 (IQR -3.1;-1.3). The median WAZ was -1.5 (IQR -2.5;-0.8), with 29.2% being underweight-for-age (WAZ <-2). The peak height velocity (PHV) in adolescents with baseline stage 3 disease was higher than for those with stage 4 disease. Being older at ART start (p<0.001) and baseline stunting (p<0.001) were associated with poorer growth, resulting in a lower HAZ at study exit, with boys more significantly affected than girls (p<0.001). CONCLUSIONS : Suboptimal growth in adolescents with perinatally-acquired HIV infection is a significant health concern, especially in children who started ART later in terms of age and who had baseline stunting and is more pronounced in boys than in girls. en_US
dc.description.department Paediatrics and Child Health en_US
dc.description.librarian dm2022 en_US
dc.description.uri http://www.plosone.org en_US
dc.identifier.citation Mwambenu, B., Ramoloko, V., Laubscher, R. & Feucht, U. (2022) Growth and the pubertal growth spurt in South African adolescents living with perinatally-acquired HIV infection. PLoS One 17(1): e0262816. https://doi.org/10.1371/journal.pone.0262816. en_US
dc.identifier.issn 1932-6203 (online)
dc.identifier.other 10.1371/journal. pone.0262816
dc.identifier.uri https://repository.up.ac.za/handle/2263/88161
dc.language.iso en en_US
dc.publisher Public Library Science en_US
dc.rights © 2022 Mwambenu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License. en_US
dc.subject Antiretroviral therapy (ART) en_US
dc.subject Adolescents en_US
dc.subject Children living with HIV (CLWH) en_US
dc.subject Growth patterns en_US
dc.subject Suboptimal growth en_US
dc.subject Perinatally-acquired HIV infection en_US
dc.title Growth and the pubertal growth spurt in South African adolescents living with perinatally-acquired HIV infection en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record